Average Co-Inventor Count = 13.30
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Lycera Corporation (5 from 36 patents)
3. Merck Canada Inc. (1 from 40 patents)
12 patents:
1. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
2. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
3. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
4. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
5. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
6. 9745265 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
7. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
8. 9556168 - N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof
9. 9216173 - 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
10. 9145391 - Bipyridylaminopyridines as Syk inhibitors
11. 9023865 - Compounds that are ERK inhibitors
12. 8999957 - Heterocyclic compounds as ERK inhibitors